Jubilant Organosys
Jubilant Organosys Ltd., one of the largest custom research
and manufacturing services (CRAMS) companies, is a composite
pharmaceutical industry player offering products and services
to global life sciences companies. We have presence across
the pharmaceuticals value chain right from drug discovery
and chemistry services to custom research and manufacturing
of advance intermediates, fine chemicals and Active Pharmaceutical
Ingredients upto regulatory services, development, licensing
and supply of formulations and clinical research.
We have three subsidiary companies in India - Jubilant Biosys
Ltd. for bio / chemo informatics databases for drug discovery
companies, Jubilant Chemsys for medicinal chemistry and Jubilant
Clinsys Ltd. for clinical research. Jubilant Organosys has
a strong international presence having international subsidiaries
at Belgium, USA and China. Jubilant products are sold across
the globe in more than 60 countries.
We deliver products and services to the global life sciences
industry by leveraging our R&D expertise, knowledge-driven
operations and global scale manufacturing capacities. Jubilant
is headquartered in Noida, near New Delhi, with gross sales
of US $350 million and more than 2,400 employees.
The meaning of Organosys derives from an amalgamation of Organic i.e. life and nature and Sys i.e. systems, synthesis and science. This combination makes Jubilant Organosys a powerful company that is positioned as ScienceActive, as the company moves up the value chain by focusing on research-based knowledge industries.
The business of Jubilant Organosys is organized into three
divisions. The individual businesses have fully integrated
strategic business units.
Jubilant Biosys
In keeping with the positioning as ScienceActive, Jubilant
Organosys has also invested in the Bioinformatics and Chemoinformatics
sectors through an associate company called Jubilant Biosys
based in Bangalore, India. Jubilant Biosys is an innovative
bioinformatics and chemoinformatics service provider specializing
in providing high quality knowledge bases and informatics
solutions for pharmaceutical and biotechnology companies.
The Company undertakes Custom Curation services and provides
databases like Ligand-centric databases, Gene / protein-centric
databases and Pathway centric databases. The skilled IT team
works closely with domain experts to provide Custom application
development, Database integration services and Front-end design.
The key products of the Company include Kinase ChemBioBase,
Pathway databases, GPCR Annotator, Nitrilase and Nitrile Hydratase
database, Caspase database and Protease Inhibitors database.
Jubilant Chemsys
Jubilant offers chemistry based drug discovery and development
services ranging from early stage lead discovery and optimization
to the identification of viable synthetic routes required
to manufacture kg quantities of NCE for pre-clinical and clinical
studies. Our services integrate the expertise of our scientists
in the areas of Drug Discovery, Drug Development and Analytical
Chemistry.
Jubilant's strict adherence to IP protection and regulatory
compliance and its assured delivery and competitive pricing
has enabled it to service large pharma companies worldwide.
Jubilant Clinsys
Jubilant offers bioavailability, bioequivalence, pharmacokinetic
and phase 1 studies as per ICH-GCP and USFDA guidelines. The
company has set up a state-of-the-art facility in Noida, new
New Delhi. Jubilant aims to be the best clinical and bio
analytical service provider to serve the global generic and
NCE pharmaceutical companies in their endeavor for excellence
and cost effectiveness.
PSI & PSI Supply
Jubilant's subsidiary companies PSI & PSI Supply, based
in Belgium, are engaged in Formulation Development, Licensing
of Marketing Authorizations and supply of Finished Dosage Forms.
Company undertakes development of first-to-market generics,
NDDS, OTCs and line extensions. Company has a portfolio of products,
result of its own development activities, which is available
for licensing in various European countries. Licensing allows
the generic pharmaceutical companies to market & sell the
formulated dosage forms to end customers. Company provides licensing
with complete regulatory support, supply of active ingredient
and finished dosage forms.
|
|

|